Skip to main content

Table 3 LHRH-receptor expression of human specimens of TNBC

From: Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

 

LHRH-R negative samples

LHRH-R positive samples

absolute

percent

absolute

percent

T

    

T1

14

40

12

35

T2

17

49

18

53

T3

2

6

1

3

T4

0

0

2

5,9

Unknown

2

5,7

1

2,9

N

    

+

11

31

7

21

-

18

51

19

56

unknown

7

20

8

23

Grading

    

G1

0

0

1

3

G2

10

29

7

21

G3

25

71

26

77

Histology

    

invasive ductal

29

82,8

28

82,3

invasive lobular

1

2,9

0

0

medullary

5

14,3

6

17,6

  1. The LHRH-receptor positive and negative patient groups are descriptively compared with respect to size, nodal status, grading and histology of the tumors.